
Opinion|Videos|May 22, 2024
Venetoclax-Based Treatment Clinical Trial Updates
Yuliya Linhares, MD, discusses the CLL14 study, which is looking at venetoclax plus obinutuzumab in patients with previously untreated chronic lymphocytic leukemia.
Advertisement
Episodes in this series

Advertisement
Advertisement
Advertisement
Trending on CURE
1
New Myelofibrosis Guidelines Back Wider Gene Testing at Diagnosis
2
FDA Clears AI Tool Using MRI to Gauge Breast Cancer Recurrence
3
FDA Approves Jemperli for dMMR Locally Advanced Rectal Cancer
4
Allowing Myself to Lean into a False Reality: The Comfort of Hope
5



